Shereen M. Aleidi

1.2k total citations · 1 hit paper
35 papers, 480 citations indexed

About

Shereen M. Aleidi is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Shereen M. Aleidi has authored 35 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Oncology. Recurrent topics in Shereen M. Aleidi's work include Metabolomics and Mass Spectrometry Studies (7 papers), Cholesterol and Lipid Metabolism (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Shereen M. Aleidi is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (7 papers), Cholesterol and Lipid Metabolism (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Shereen M. Aleidi collaborates with scholars based in Jordan, Saudi Arabia and Australia. Shereen M. Aleidi's co-authors include Yasser Bustanji, Ingrid C. Gelissen, Andrew J. Brown, Mohammad Khalil, Anas M. Abdel Rahman, Ala Issa, Hicham Benabdelkamel, Laura J. Sharpe, Mysoon M. Al‐Ansari and Eman Elayeh and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Shereen M. Aleidi

31 papers receiving 473 citations

Hit Papers

Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: E... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
    2024 54 citations Shereen M. Aleidi, Jalal Taneera et al. Pharmaceuticals profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shereen M. Aleidi Jordan 12 215 86 78 75 74 35 480
Xuan Qi China 12 151 0.7× 50 0.6× 62 0.8× 112 1.5× 102 1.4× 39 540
Hyo Jeong Kim South Korea 12 175 0.8× 45 0.5× 52 0.7× 84 1.1× 22 0.3× 27 435
Marta Włodarczyk Poland 15 175 0.8× 97 1.1× 62 0.8× 85 1.1× 140 1.9× 44 939
Jai Parkash United States 12 328 1.5× 61 0.7× 51 0.7× 40 0.5× 65 0.9× 24 596
Kazuya Maeda Japan 15 237 1.1× 139 1.6× 99 1.3× 23 0.3× 160 2.2× 92 782
Jin Hyun Nam South Korea 12 137 0.6× 41 0.5× 61 0.8× 98 1.3× 90 1.2× 42 480
Renata Saucedo Mexico 16 156 0.7× 53 0.6× 63 0.8× 157 2.1× 98 1.3× 77 836

Countries citing papers authored by Shereen M. Aleidi

Since Specialization
Citations

This map shows the geographic impact of Shereen M. Aleidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shereen M. Aleidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shereen M. Aleidi more than expected).

Fields of papers citing papers by Shereen M. Aleidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shereen M. Aleidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shereen M. Aleidi. The network helps show where Shereen M. Aleidi may publish in the future.

Co-authorship network of co-authors of Shereen M. Aleidi

This figure shows the co-authorship network connecting the top 25 collaborators of Shereen M. Aleidi. A scholar is included among the top collaborators of Shereen M. Aleidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shereen M. Aleidi. Shereen M. Aleidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abuhelwa, Ahmad Y., Mohammad A. Y. Alqudah, Shereen M. Aleidi, et al.. (2025). Exosomal biomarkers in cancer: Insights from Multi-OMIC approaches. Clinica Chimica Acta. 579. 120606–120606.
3.
4.
Aleidi, Shereen M., et al.. (2024). Research Trend in The Inhibition of Transient Receptor Potential Vanilloid 1 (TRPV1): Bibliometric Analysis and Visualization. Journal of Applied Pharmaceutical Science. 1 indexed citations
5.
Alqahtani, Faleh, Thamer H. Albekairi, Shereen M. Aleidi, et al.. (2024). Metabolomics and pathways analyses in traumatic brain injury animal model. Journal of King Saud University - Science. 36(11). 103470–103470. 2 indexed citations
6.
Aleidi, Shereen M., et al.. (2024). Postprandial Metabolomic Profiling: Insights into Macronutrient-Specific Metabolic Responses in Healthy Individuals. Nutrients. 16(21). 3783–3783. 1 indexed citations
7.
Aleidi, Shereen M., Jalal Taneera, Eman Abu‐Gharbieh, et al.. (2024). Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation. Pharmaceuticals. 17(2). 195–195. 54 indexed citations breakdown →
8.
9.
Aleidi, Shereen M., et al.. (2023). Metabolomics in diabetes mellitus: clinical insight. Expert Review of Proteomics. 20(12). 451–467. 3 indexed citations
10.
Mujammami, Muhammad, Shereen M. Aleidi, Hicham Benabdelkamel, et al.. (2023). Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential. Pharmaceuticals. 16(12). 1717–1717. 3 indexed citations
11.
Aleidi, Shereen M., et al.. (2022). Lipidomics Profiling of Patients with Low Bone Mineral Density (LBMD). International Journal of Molecular Sciences. 23(19). 12017–12017. 27 indexed citations
12.
Al‐Ansari, Mysoon M., et al.. (2022). Proteomics Profiling of Osteoporosis and Osteopenia Patients and Associated Network Analysis. International Journal of Molecular Sciences. 23(17). 10200–10200. 19 indexed citations
13.
Al‐Iede, Montaha, et al.. (2021). The impact of using a mobile application to improve asthma patients’ adherence to medication in Jordan. Health Informatics Journal. 27(3). 1187528302–1187528302. 7 indexed citations
14.
Aleidi, Shereen M., et al.. (2021). A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients. Metabolites. 11(9). 628–628. 33 indexed citations
15.
Aleidi, Shereen M., Lina A. Dahabiyeh, Hicham Benabdelkamel, et al.. (2021). Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin. Frontiers in Pharmacology. 11. 616157–616157. 25 indexed citations
16.
Aleidi, Shereen M., et al.. (2020). Factors Affecting the Academic Performance of Medical, Dental, and Pharmacy Students in Jordan. Jordan Journal of Pharmaceutical Sciences. 13(2). 9 indexed citations
17.
18.
Aleidi, Shereen M., et al.. (2019). Serum level of insulin-like growth factor-I in type 2 diabetic patients: impact of obesity. Hormone Molecular Biology and Clinical Investigation. 39(1). 10 indexed citations
19.
Aleidi, Shereen M., et al.. (2019). The Adaptor Protein Alix is Involved in the Interaction Between the Ubiquitin Ligase NEDD4-1 and its Targets, ABCG1 and ABCG4. International Journal of Molecular Sciences. 20(11). 2714–2714. 11 indexed citations
20.
Sharpe, Laura J., Peter M. Jones, Shereen M. Aleidi, et al.. (2015). Cholesterol sensing by the ABCG1 lipid transporter: Requirement of a CRAC motif in the final transmembrane domain. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(7). 956–964. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuan Qi Breakdown of academic impact, for papers by Hyo Jeong Kim Breakdown of academic impact, for papers by Marta Włodarczyk Breakdown of academic impact, for papers by Jai Parkash Breakdown of academic impact, for papers by Kazuya Maeda Breakdown of academic impact, for papers by Jin Hyun Nam Breakdown of academic impact, for papers by Renata Saucedo
Rankless by CCL
2026